(2022) Dose-response relationship between weight loss and improvements in obstructive sleep apnea severity after a diet/lifestyle interventions: secondary analyses of the MIMOSA randomized clinical trial Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Olukorode, John O., et al (2024) Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders Gonzolaz-Rellan, Maria J., Drucker, Daniel J
Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should discuss the risks of thyroid tumors with their healthcare provider
This detailed report provides a systemic picture of your health by analyzing key biomarkers
Participants who received the sham procedure regained about 40% more weight than those who underwent the actual treatment
doi: 10.1097/prs.0000000000007783 7 SchaverienMVAsaadMSelberJCLiuJChenDNHallMSet al
